{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:45:34Z","timestamp":1785789934017,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bpobgyn.2014.04.023","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T06:49:17Z","timestamp":1408603757000},"page":"156-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Metabolomics and the great obstetrical syndromes \u2013 GDM, PET, and IUGR"],"prefix":"10.1016","volume":"29","author":[{"given":"Angelica","family":"Dess\u00ec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-5957","authenticated-orcid":false,"given":"Flamina Cesare","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Fanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.04.023_bib1","series-title":"Cardiovascular pathophysiology of hypertensive disorders in pregnancy in medical therapy in pregnancy","author":"Dekker","year":"1998"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Metabolomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical applications of metabolomics in oncology: a review","volume":"15","author":"Spratlin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0148607112462401","article-title":"Highlights of the 2012 research workshop: using nutrigenomics and metabolomics in clinical nutrition research","volume":"37","author":"Zeisel","year":"2013","journal-title":"J\u00a0Parent Ent Nutr"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aca.2009.11.042","article-title":"Chemometrics in metabolomics\u2014a review in human disease diagnosis","volume":"659","author":"Madsen","year":"2010","journal-title":"Anal Chim Act"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-12-394383-5.00013-8","article-title":"Urinary metabolomics in the newborn and infants","volume":"58","author":"Fanos","year":"2012","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/14767058.2012.663198","article-title":"Clinical application of metabolism in neonatology","volume":"1","author":"Fanos","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.siny.2012.10.014","article-title":"Metabolomics in neonatology: fact or fiction?","volume":"18","author":"Fanos","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(09)60515-8","article-title":"Gestational diabetes: the need for a common ground","volume":"373","author":"Reece","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.beem.2010.06.001","article-title":"The maternal and fetal impacts of obesity and gestational diabetes on pregnancy outcome","volume":"24","author":"Dennedy","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib12","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.3390\/molecules181011724","article-title":"Metabolomics and fetal-neonatal nutrition: between \u201cnot enough\u201d and \u201ctoo much\u201d","volume":"18","author":"Dess\u00ec","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib13","first-page":"B9","article-title":"Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age","volume":"21","author":"King","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib14","first-page":"358","article-title":"Epidemiology of diabetes in pregnancy: a review of Italian data","volume":"17","author":"Lapolla","year":"2004","journal-title":"Diab Nutr Metab"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib15","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1021\/pr100815q","article-title":"Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study","volume":"9","author":"Gra\u00e7a","year":"2010","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib16","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1021\/pr200352m","article-title":"Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma","volume":"10","author":"Diaz","year":"2011","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1039\/c2mb05424h","article-title":"UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers","volume":"8","author":"Gra\u00e7a","year":"2012","journal-title":"Mol BioSyst"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib18","doi-asserted-by":"crossref","first-page":"e52399","DOI":"10.1371\/journal.pone.0052399","article-title":"Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes","volume":"7","author":"Sachse","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib19","unstructured":"Logan KM, Wijeyesekera AD, Perez IG et\u00a0al. Infants of mothers with diabetes have altered urinary metabolic profile at birth. Available at: www.neonatalsociety.ac.uk\/abstracts\/logank_2012_diabeticurinaryprofile.shtml (last accessed 27.03.14)."},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/14767058.2013.823941","article-title":"Metabolomic profile of term infants of gestational diabetic mothers","volume":"27","author":"Dani","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"Pre-eclampsia, the placenta and the maternal systemic inflammatory response\u2014a review","volume":"24","author":"Redman","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11306-005-0003-1","article-title":"Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning","volume":"1","author":"Kenny","year":"2005","journal-title":"Metabolomics"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1933719108316908","article-title":"Detection and identification of novel metabolomic biomarkers in preeclampsia","volume":"15","author":"Kenny","year":"2008","journal-title":"Reproductive Sciences"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","article-title":"Screening for Pregnancy Endpoints Consortium. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers","volume":"56","author":"Kenny","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/pd.2822","article-title":"First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study","volume":"31","author":"Odibo","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.placenta.2009.08.008","article-title":"Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia","volume":"30","author":"Dunn","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib27","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","article-title":"Metabolomics and first-trimester prediction of early-onset preeclampsia","volume":"25","author":"Bahado-Singh","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib28","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2012.11.003","article-title":"First-trimester metabolomic detection of late-onset preeclampsia","volume":"208","author":"Bahado-Singh","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0020-7292(00)90000-6","article-title":"Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists","volume":"72","author":"Committee on Practice Bulletins Gynecology, American College of Obstetricians and Gynecologists, Washington, DC 20090-6920, USA","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib30","first-page":"612","article-title":"Perinatal energy metabolism with reference to IUGR & SGA: studies in pregnant women & newborn infants","volume":"130","author":"Diderholm","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib31","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1471-0528.2010.02737.x","article-title":"SCOPE consortium. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study","volume":"117","author":"McCowan","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib32","first-page":"395","article-title":"Type 2 (non insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/14767058.2012.714639","article-title":"Physiopathology of intrauterine growth retardation: from classic data to metabolomics","volume":"25","author":"Dess\u00ec","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bmj.311.6998.171","article-title":"Fetal origins of coronary heart disease","volume":"311","author":"Barker","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.placenta.2010.06.011","article-title":"First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies","volume":"31","author":"Hafner","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/1471-0528.12172","article-title":"Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis","volume":"120","author":"Conde-Agudelo","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/378268","article-title":"Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes","author":"Nissen","year":"2011","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/14767058.2011.605868","article-title":"Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolomic syndrome","volume":"2","author":"Dess\u00ec","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/01443615.2013.831046","article-title":"Myoinositol: a new marker of intrauterine growth restriction?","volume":"33","author":"Dess\u00ec","year":"2013","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib40","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1021\/pr2003193","article-title":"Offspring metabolomic response to maternal protein restriction in a rat model of intrauterine growth restriction (IUGR)","volume":"10","author":"Alexandre-Gouabau","year":"2011","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.placenta.2010.07.002","article-title":"Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies","volume":"31","author":"Horgan","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00216-011-5540-z","article-title":"Cord blood metabolomic profiling in intrauterine growth restriction","volume":"402","author":"Favretto","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib43","first-page":"990","article-title":"Metabolomic analysis reveals differences in umbilical vein plasma metabolites between normal and growth-restricted fetal pigs during late gestation","volume":"142","author":"Lin","year":"2012","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib44","doi-asserted-by":"crossref","first-page":"e64545","DOI":"10.1371\/journal.pone.0064545","article-title":"Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain","volume":"8","author":"van Vliet","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1017\/thg.2013.33","article-title":"Selective intrauterine growth restriction in monochorionic twin pregnancies: markers of endothelial damage and metabolomic profile","volume":"16","author":"Cosmi","year":"2013","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.bpobgyn.2014.04.023_bib46","doi-asserted-by":"crossref","first-page":"e80121","DOI":"10.1371\/journal.pone.0080121","article-title":"Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation","volume":"8","author":"Sanz-Cort\u00e9s","year":"2013","journal-title":"PLoS One"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T01:00:40Z","timestamp":1565744440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1521693414001710"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.023","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics and the great obstetrical syndromes \u2013 GDM, PET, and IUGR","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}